切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2026, Vol. 20 ›› Issue (01) : 48 -52. doi: 10.3877/cma.j.issn.1674-0793.2026.01.009

所属专题: 文献

综述

细胞外体积分数在肝胆胰外科疾病诊疗中的应用价值及发展前景展望
徐晗, 陈哲, 谈燚()   
  1. 233004 蚌埠,蚌埠医科大学第一附属医院肝胆胰外科
  • 收稿日期:2025-08-09 出版日期:2026-02-01
  • 通信作者: 谈燚
  • 基金资助:
    安徽省教育厅重点项目(2022AH051416)

Values of extracellular volume fraction in the diagnosis and treatment of hepatic-biliary-pancreatic surgical diseases and the prospects of its development

Han Xu, Zhe Chen, Yi Tan()   

  1. Department of Hepatic-biliary-pancreatic Surgery, the First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China
  • Received:2025-08-09 Published:2026-02-01
  • Corresponding author: Yi Tan
引用本文:

徐晗, 陈哲, 谈燚. 细胞外体积分数在肝胆胰外科疾病诊疗中的应用价值及发展前景展望[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 48-52.

Han Xu, Zhe Chen, Yi Tan. Values of extracellular volume fraction in the diagnosis and treatment of hepatic-biliary-pancreatic surgical diseases and the prospects of its development[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(01): 48-52.

基于CT及MRI技术计算的细胞外体积分数(ECVf)作为近年来新兴的影像学量化指标,可实现对细胞外体积的无创性定量分析。相较于传统有创穿刺活检技术,其具有创伤小、获取便捷等显著优势。在临床实践中,ECVf为器官纤维化程度评估、肿瘤预后判断、病理分型预测等多种临床问题提供了全新的量化指标,为相关疾病的诊疗提供了创新性思路。本文将从ECVf的发展历程、计算方法、在肝胆胰外科疾病诊疗中的应用价值及发展前景展开综述。

As an emerging quantitative imaging index in recent years, the extracellular volume fraction (ECVf), calculated based on CT and MRI techniques, enables non-invasive quantitative analysis of extracellular volume. Compared with the traditional invasive puncture biopsy technique, it has the advantages of less trauma and easier access. In clinical practice, ECVf provides a novel quantitative index for assessing the degree of organ fibrosis, predicting the tumor prognosis, and determining pathologic staging, offering innovative insights for the diagnosis and treatment of related diseases. In this article, we will systematically review the development, calculation method, and application value of ECVf in hepatic-biliary-pancreatic surgical diseases, and its development prospects.

[1]
吴江为, 张巧玲, 王选银, 等. CD248+CAFs激活Hippo通路介导细胞外基质重塑促进NSCLC转移的机制研究[J]. 医用生物力学, 2024, 39(S01): 124.
[2]
樊永亮, 霍云龙. 细胞外基质微环境在心脏纤维化发生发展中的作用和机制[J]. 医用生物力学, 2024, 39(S01): 352–353.
[3]
Nicholson C, Phillips JM. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum[J]. J Physiol, 1981, 321: 225–257.
[4]
徐馨炀, 王可欣, 李忠. 基于影像学的细胞外体积分数的研究进展[J]. 中国现代医生, 2024, 62(33): 135–138, 146.
[5]
Hui Z, Huimin G, Guangyao L, et al. CT for the evaluation of myocardial extracellular volume with MRI as reference: A systematic review and meta-analysis[J]. Eur Radiol, 2023, 33(12): 8464–8476.
[6]
Liu P, Lin L, Xu C, et al. Quantitative analysis of late iodine enhancement using dual-layer spectral detector computed tomography: comparison with magnetic resonance imaging[J]. Quant Imaging Med Surg, 2022, 12(1): 310–320.
[7]
Sun S, Huang B, Li Q, et al. Prediction of pancreatic fibrosis by dual-energy CT-derived extracellular volume fraction: comparison with MRI[J]. Eur J Radiol, 2024, 170: 111204.
[8]
周欣冉, 邹梦梦, 岳凤辉, 等. 基于增强CT的细胞外体积分数联合常规检验标志物在肝癌分级中的预测价值[J]. 分子影像学杂志, 2024, 47(4): 379–385.
[9]
何源青, 郭雷明, 冯佩, 等. 钆塞酸二钠增强MRI多模态参数与原发性肝癌患者病情程度的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(4): 317-325.
[10]
Peng Y, Tang H, Huang Y, et al. CT-derived extracellular volume and liver volumetry can predict posthepatectomy liver failure in hepatocellular carcinoma[J]. Insights Imaging, 2023, 14(1): 145.
[11]
Iwaya H, Fukukura Y, Hashimoto S, et al. Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms[J]. Pancreatology, 2021, 21(4): 779–786.
[12]
Cai W, Zhu Y, Li D, et al. Baseline body composition and 3D-extracellular volume fraction for predicting pancreatic fistula after distal pancreatectomy in pancreatic body and/or tail adenocarcinoma[J]. Acad Radiol, 2025, 32(4): 2027–2040.
[13]
杜楠, 魏妙艳, 徐近. 胰腺癌的靶向治疗进展及前沿[J]. 中国临床药理学与治疗学, 2025, 30(2): 183–192.
[14]
Noid G, Godfrey G, Hall W, et al. Predicting treatment response from extracellular volume fraction for chemoradiation therapy of pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2023, 115(3): 803–808.
[15]
Liu W, Chen Y, Xie T, et al. Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients[J]. Eur Radiol, 2025, 35(3): 1451–1463.
[16]
Xiong J, Lu Y, Liu H, et al. Extracellular volume derived from equilibrium CT for the prediction of survival outcomes in patients with pancreatic ductal adenocarcinoma[J]. Technol Cancer Res Treat, 2025, 24: 15330338251336032.
[17]
Fujita N, Ushijima Y, Itoyama M, et al. Extracellular volume fraction determined by dual-layer spectral detector CT: possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma[J]. Eur J Radiol, 2023, 162: 110756.
[18]
Fukukura Y, Kumagae Y, Higashi R, et al. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage Ⅳpancreatic ductal adenocarcinoma[J]. Eur Radiol, 2020, 30(3): 1679–1689.
[19]
Takayama Y, Koga T, Hamada Y, et al. Prediction of the wall-invasion pattern of advanced gallbladder carcinoma using extracellular volume fraction[J]. Jpn J Radiol, 2025, 43(8): 1323–1334.
[20]
Honda T, Onishi H, Fukui H, et al. Extracellular volume fraction using contrast-enhanced CT is useful in differentiating intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma[J]. Front Oncol, 2023, 13: 1214977.
[21]
师雨琛, 李小强. TRPV1通道在小鼠组织纤维化中的作用研究进展[J]. 中国实验动物学报, 2025, 33(2): 259–266.
[22]
Sofue K, Ueshima E, Masuda A, et al. Estimation of pancreatic fibrosis and prediction of postoperative pancreatic fistula using extracellular volume fraction in multiphasic contrast-enhanced CT[J]. Eur Radiol, 2022, 32(3): 1770–1780.
[23]
Fukui H, Onishi H, Ota T, et al. Pancreatic fibrosis assessment and association with pancreatic cancer: comparison with the extracellular volume fraction[J]. Clin Radiol, 2024, 79(11): e1356-e1365.
[24]
Kai K, Hiyoshi M, Imamura N, et al. A preliminary pathological evaluation of extracellular volume fraction with contrast-enhanced computed tomography as a novel quantitative parameter of pancreatic fibrosis[J]. Intern Med, 2023, 62(8): 1107–1115.
[25]
Yoon JH, Lee JM, Kim JH, et al. Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT[J]. Eur J Radiol, 2021, 137: 109604.
[26]
Liang Z, Liu Y, Nie Y. Efficacy analysis of double-low dynamic contrast-enhanced CT and hepatic extracellular volume fraction in the diagnosis of liver fibrosis[J]. Contrast Media Mol Imaging, 2022, 2022: 8089914.
[27]
Mesropyan N, Kupczyk P, Dold L, et al. Non-invasive assessment of liver fibrosis in autoimmune hepatitis: diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction[J]. Abdom Radiol(NY), 2021, 46(6): 2458–2466.
[28]
朱祖辉, 邢伟, 刘海峰, 等. 钆塞酸二钠T1 mapping磁共振成像定量评估兔肝纤维化的研究[J]. 磁共振成像, 2020, 11(10): 890–895.
[29]
芮茂萍, 朱晓艳, 吕梁, 等. 磁共振细胞外容积分数联合PDFF成像在NAFLD食蟹猴模型中对早期肝脏纤维化的诊断价值[J]. 中国CT和MRI杂志, 2024, 22(5): 120–122.
[30]
Dasyam AK, Shah ZK, Tirkes T, et al. Cross-sectional imaging-based severity scoring of chronic pancreatitis: why it is necessary and how it can be done[J]. Abdom Radiol (NY), 2020, 45(5): 1447–1457.
[31]
Tirkes T, Yadav D, Conwell DL, et al. Multiparametric MRI scoring system of the pancreas for the diagnosis of chronic pancreatitis[J]. J Magn Reson Imaging, 2024, 61(5): 2183–2194.
[32]
Evrimler S, Swensson JK, Are VS, et al. Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging[J]. Abdom Radiol (NY), 2020, 46(6): 2433–2443.
[1] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J/OL]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[2] 李敏, 杨世英, 高晓琴, 周丹, 唐筱, 张立婷. 维生素A与慢性肝病相关性研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 65-70.
[3] 张麒, 马臻. 丙型肝炎肝纤维化进展影响因素及标志物研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 1-6.
[4] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[5] 徐竟益, 孙凯, 王爽, 吴柳盛, 梁悦华, 杨宇帆, 赵雨桐, 杨雷, 王文强, 闫军. 吲哚菁绿在肝胆胰外科中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 91-95.
[6] 希龙夫, 薛荣泉. 人工智能在肝胆胰肿瘤诊治中应用与进展[J/OL]. 中华腔镜外科杂志(电子版), 2025, 18(03): 166-171.
[7] 李雪铭, 伊诺, 卢智豪, 冯婧, 董健藤, 李健. 人脐带间充质干细胞来源外泌体抑制肝星状细胞活化发挥抗肝纤维化作用的实验研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(03): 148-156.
[8] 曹键, 孟占鳌, 张可, 张悦, 郭亚豪, 邓锶锶, 罗涛, 朱璇, 覃杰, 黎超, 唐天濠, 陈颖坤, 向青. 基于血清学指标和MRI构建肝纤维化分期诊断双模态模型与验证[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(06): 902-911.
[9] 翟航, 张广权, 吴芳芳, 史宪杰. 非编码RNA调控胰腺纤维化研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 583-587.
[10] 李娅敏, 吕新蕾, 史秀梅, 王月云, 盛欧, 卜高峰, 成松, 谢士宁. 富马酸丙酚替诺福韦治疗慢性乙型肝炎获得病毒学应答后肝纤维化逆转的影响因素[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 359-363.
[11] 江浩, 余宏圣, 杨碧兰, 阿布都克尤木·斯马依, 吴斌, 杨逸冬. 基于列线图模型对慢性乙型肝炎合并肝脏脂肪变性患者并发晚期肝纤维化的临床预测[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 114-120.
[12] 希龙夫, 李江涛. CXCL12及其受体CXCR4/CXCR7在肝脏相关疾病中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(09): 714-719.
[13] 冉影, 刘瑞云, 王欣宇, 顾家琪, 韩宗泽, 李纪文, 杨辉, 王翛然, 王邦茂, 周璐. 瞬时弹性成像对自身免疫性肝炎肝纤维化的诊断效能及其影响因素[J/OL]. 中华临床医师杂志(电子版), 2025, 19(09): 651-658.
[14] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[15] 张娜, 鲁志宏, 张盛军, 陈启众, 俞永涛, 陈申思, 钱海权, 刘轲. 腹腔镜袖状胃切除术治疗肥胖合并非酒精性脂肪肝患者肝纤维化的短期疗效分析[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(04): 261-266.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?